A detailed history of Eldridge Investment Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Eldridge Investment Advisors, Inc. holds 8,093 shares of MRK stock, worth $804,848. This represents 0.22% of its overall portfolio holdings.

Number of Shares
8,093
Previous 8,249 1.89%
Holding current value
$804,848
Previous $1.02 Million 9.99%
% of portfolio
0.22%
Previous 0.26%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$111.15 - $128.97 $17,339 - $20,119
-156 Reduced 1.89%
8,093 $919,000
Q2 2024

Aug 01, 2024

BUY
$123.8 - $132.96 $37,759 - $40,552
305 Added 3.84%
8,249 $1.02 Million
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $39,067 - $45,522
345 Added 4.54%
7,944 $1.05 Million
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $500 - $545
5 Added 0.07%
7,599 $828,000
Q3 2023

Nov 06, 2023

BUY
$102.95 - $114.33 $514 - $571
5 Added 0.07%
7,594 $782,000
Q2 2023

Aug 03, 2023

BUY
$108.61 - $118.38 $6,951 - $7,576
64 Added 0.85%
7,589 $876,000
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $5,147 - $5,743
-50 Reduced 0.66%
7,525 $801,000
Q4 2022

Feb 03, 2023

BUY
$87.44 - $112.11 $22,821 - $29,260
261 Added 3.57%
7,575 $840,000
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $422 - $474
5 Added 0.07%
7,314 $630,000
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $417 - $473
5 Added 0.07%
7,309 $666,000
Q1 2022

May 10, 2022

BUY
$73.51 - $82.4 $514 - $576
7 Added 0.1%
7,304 $599,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $361 - $452
5 Added 0.07%
7,297 $559,000
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $430 - $472
6 Added 0.08%
7,292 $548,000
Q2 2021

Aug 05, 2021

BUY
$70.31 - $77.77 $421 - $466
6 Added 0.08%
7,286 $567,000
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $344 - $405
5 Added 0.07%
7,280 $561,000
Q4 2020

Feb 11, 2021

BUY
$71.77 - $79.65 $358 - $398
5 Added 0.07%
7,275 $595,000
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $219 - $248
3 Added 0.04%
7,270 $603,000
Q2 2020

Aug 07, 2020

BUY
$70.42 - $80.13 $492 - $560
7 Added 0.1%
7,267 $562,000
Q1 2020

May 08, 2020

BUY
$63.36 - $87.82 $253 - $351
4 Added 0.06%
7,260 $559,000
Q4 2019

Feb 03, 2020

BUY
$77.58 - $87.54 $387 - $437
5 Added 0.07%
7,256 $660,000
Q3 2019

Nov 01, 2019

BUY
$76.08 - $82.93 $304 - $331
4 Added 0.06%
7,251 $610,000
Q2 2019

Jul 29, 2019

BUY
$69.84 - $81.59 $279 - $326
4 Added 0.06%
7,247 $608,000
Q1 2019

Apr 24, 2019

BUY
$69.58 - $79.36 $347 - $396
5 Added 0.07%
7,243 $602,000
Q4 2018

Jan 24, 2019

BUY
$65.24 - $75.71 $258,415 - $299,887
3,961 Added 120.87%
7,238 $553,000
Q3 2018

Oct 11, 2018

SELL
$57.69 - $67.84 $3,172 - $3,731
-55 Reduced 1.65%
3,277 $232,000
Q2 2018

Jul 31, 2018

BUY
$50.83 - $59.72 $169,365 - $198,987
3,332 New
3,332 $202,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Eldridge Investment Advisors, Inc. Portfolio

Follow Eldridge Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eldridge Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eldridge Investment Advisors, Inc. with notifications on news.